Caroline Dean

Title: Innovations by Caroline Dean in Lysosomal Storage Disorders

Introduction

Caroline Dean is a prominent inventor based in Christies Beach, Australia. She has made significant contributions to the field of medical diagnostics, particularly in the area of lysosomal storage disorders (LSDs). With a total of three patents to her name, her work focuses on innovative methods for testing and profiling lysosomal health.

Latest Patents

Caroline Dean's latest patents include a novel protein profiling method for testing lysosomal storage diseases. This method utilizes discovered normalized lysosomal fingerprint patterns that reveal the health of lysosomal organelles, specific LSDs, and clinical severity. Additionally, her work involves multiplexing bead technology, which allows for simultaneous screening of multiple LSDs while normalizing measured enzyme activity or protein levels against other lysosomal proteins, enzymes, or enzyme activities. Furthermore, she has developed compounds, reagents, and methods for identifying and quantifying multiple target enzymes and proteins.

Career Highlights

Caroline Dean is affiliated with the Women's and Children's Hospital, where she applies her expertise in lysosomal storage disorders. Her innovative approaches have the potential to transform diagnostic practices and improve patient outcomes.

Collaborations

Some of her notable coworkers include Peter John Meikle and John Joseph Hopwood, who contribute to her research and development efforts in the field.

Conclusion

Caroline Dean's work in lysosomal storage disorders exemplifies the impact of innovation in medical diagnostics. Her patents and collaborations highlight her commitment to advancing healthcare through scientific discovery.